Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$968K Buy
744,963
+387,385
+108% +$534K ﹤0.01% 3019
2026
Q1
$461K Buy
357,578
+298,659
+507% +$493K ﹤0.01% 3167
2025
Q4
$130K Buy
58,919
+34,828
+145% +$65.5K ﹤0.01% 3439
2025
Q3
$39K Sell
24,091
-9,269
-28% -$19.4K ﹤0.01% 3430
2025
Q2
$86.4K Buy
33,360
+12,164
+57% +$48K ﹤0.01% 3202
2025
Q1
$143K Sell
21,196
-7,098
-25% -$50.3K ﹤0.01% 2950
2024
Q4
$192K Sell
28,294
-35,469
-56% -$234K ﹤0.01% 2679
2024
Q3
$529K Buy
63,763
+52,704
+477% +$381K ﹤0.01% 2148
2024
Q2
$70.1K Sell
11,059
-48,671
-81% -$374K ﹤0.01% 2522
2024
Q1
$554K Buy
59,730
+25,064
+72% +$294K ﹤0.01% 1928
2023
Q4
$442K Buy
+34,666
New +$361K ﹤0.01% 1935
2023
Q1
Sell
-53,332
Closed -$450K 2219
2022
Q4
$450K Buy
+53,332
New +$507K ﹤0.01% 1849

Other funds holding LUNG

Cliff Asness's LUNG Position: Q2 2026 in Review

Cliff Asness increased its Pulmonx (LUNG) stake by 108% in Q2 2026, buying an estimated $534K and bringing the position to 744,963 shares worth $968K. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

Cliff Asness first reported a position in LUNG in Q4 2022 and has held it in 12 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Cliff Asness held 744,963 shares of Pulmonx worth $968K as of Q2 2026.
  • Cliff Asness bought 387,385 Pulmonx shares in Q2 2026, an estimated $534K.
  • Pulmonx made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3019 holding.
  • Cliff Asness first reported a position in Pulmonx in Q4 2022 and has held it in 12 quarters since.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.